CPAC-SPAC.ST
Creaspac AB (publ) [CPAC-SPAC.ST] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CPAC-SPAC.ST Stock Summary
Top 10 Correlated ETFs
CPAC-SPAC.ST
Top 10 Correlated Stocks
CPAC-SPAC.ST
In the News
CPAC-SPAC.ST Financial details
Company Rating
Buy
Market Cap
2.63B
Income
62M
Revenue
0
Book val./share
101.32
Cash/share
101.72
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
41.22
Forward P/E
-
PEG
1.17
P/S
-
P/B
0.98
P/C
1.02
P/FCF
40.16
Quick Ratio
4
Current Ratio
504
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
2.48
EPS next Y
-
EPS next Q
-
EPS this Y
350.91%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
5.56%
-
-
-
-
SMA20
5.05%
SMA50
6.12%
SMA100
8.33%
Inst Own
-
Inst Trans
-
ROA
2%
ROE
2%
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
93.8-105.4
52W High
-1.33%
52W Low
+11.4%
RSI
68
Rel Volume
0.45
Avg Volume
88.15K
Volume
39.56K
Perf Week
0%
Perf Month
5.5%
Perf Quarter
7.25%
Perf Half Y
7.02%
-
-
-
-
Beta
0.203
-
-
Volatility
0.64%, 2.31%
Prev Close
-0.19%
Price
103.6
Change
-0.77%
CPAC-SPAC.ST Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | |
| Net income per share | 0 | -0.77 | 0.55 | 2.48 | |
| Operating cash flow per share | 0 | -0.73 | 0.25 | 3.16 | |
| Free cash flow per share | 0 | -0.73 | 0.25 | 3.16 | |
| Cash per share | 0 | 17.15 | 8.78 | 101.72 | |
| Book value per share | 0 | 186.45 | 98.86 | 101.32 | |
| Tangible book value per share | 0 | 186.45 | 98.86 | 101.32 | |
| Share holders equity per share | 0 | 186.45 | 98.86 | 101.32 | |
| Interest debt per share | 0 | 0 | -0.57 | 0 | |
| Market cap | 0 | 1.33B | 2.38B | 2.44B | |
| Enterprise value | 0 | 1.1B | 2.16B | -108M | |
| P/E ratio | 0 | -131.4 | 173.05 | 39.27 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | |
| POCF ratio | 0 | -136.95 | 376.37 | 30.82 | |
| PFCF ratio | 0 | -136.95 | 376.37 | 30.82 | |
| P/B Ratio | 0 | 0.54 | 0.96 | 0.96 | |
| PTB ratio | 0 | 0.54 | 0.96 | 0.96 | |
| EV to sales | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | 0 | -109 | -275.75 | 18 | |
| EV to operating cash flow | 0 | -113.6 | 341.62 | -1.37 | |
| EV to free cash flow | 0 | -113.6 | 341.62 | -1.37 | |
| Earnings yield | 0 | -0.01 | 0.01 | 0.03 | |
| Free cash flow yield | 0 | -0.01 | 0 | 0.03 | |
| Debt to equity | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | 0 | 22.4 | 28.04 | 423.83 | |
| Current ratio | 0 | 1.93K | 3.11K | 254.3 | |
| Interest coverage | 0 | 0 | 0.55 | 0 | |
| Income quality | 0 | 0.96 | -0.81 | 1.27 | |
| Dividend Yield | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | |
| Graham number | 0 | 56.67 | 34.96 | 75.19 | |
| ROIC | 0 | 0 | -0.01 | 0 | |
| Return on tangible assets | 0 | 0 | 0.01 | 0.02 | |
| Graham Net | 0 | 17.1 | 8.76 | 101.32 | |
| Working capital | 25K | 2.46B | 2.46B | 2.53B | |
| Tangible asset value | 25K | 2.46B | 2.47B | 2.53B | |
| Net current asset value | 25K | 2.46B | 2.46B | 2.53B | |
| Invested capital | 0 | 0 | 0 | 0 | |
| Average receivables | 0 | 434.5K | 628K | 193.5K | |
| Average payables | 0 | 158.5K | 334K | 175.5K | |
| Average inventory | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | |
| ROE | 0 | 0 | 0.01 | 0.02 | |
| Capex per share | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | 0.67 | 0.44 | 0.56 | 0.72 | 0.76 | |
| Operating cash flow per share | 0.53 | -0.08 | 1.12 | 0.88 | 1.2 | |
| Free cash flow per share | 0.53 | -0.08 | 1.12 | 0.88 | 1.2 | |
| Cash per share | 8.78 | 8.72 | 0.76 | 0.8 | 101.72 | |
| Book value per share | 98.86 | 99.32 | 99.87 | 100.6 | 101.32 | |
| Tangible book value per share | 98.86 | 99.32 | 99.87 | 100.6 | 101.32 | |
| Share holders equity per share | 98.86 | 99.32 | 99.87 | 100.6 | 101.32 | |
| Interest debt per share | -0.45 | -0.64 | 0 | 0 | 0 | |
| Market cap | 2.38B | 2.39B | 2.38B | 2.44B | 2.44B | |
| Enterprise value | 2.16B | 2.17B | 2.36B | 2.42B | -108M | |
| P/E ratio | 35.51 | 54.2 | 42.5 | 33.85 | 32.04 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | 178.53 | -1.19K | 85 | 110.8 | 81.17 | |
| PFCF ratio | 178.53 | -1.19K | 85 | 110.8 | 81.17 | |
| P/B Ratio | 0.96 | 0.96 | 0.95 | 0.97 | 0.96 | |
| PTB ratio | 0.96 | 0.96 | 0.95 | 0.97 | 0.96 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | -1.18K | -1.08K | -1.18K | -2.42K | 108 | |
| EV to operating cash flow | 162.05 | -1.08K | 84.32 | 109.89 | -3.6 | |
| EV to free cash flow | 162.05 | -1.08K | 84.32 | 109.89 | -3.6 | |
| Earnings yield | 0.01 | 0 | 0.01 | 0.01 | 0.01 | |
| Free cash flow yield | 0.01 | 0 | 0.01 | 0.01 | 0.01 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | 120.19 | 109 | 9.5 | 20 | 2.54K | |
| Current ratio | 3.11K | 1.24K | 2.5K | 504 | 254.3 | |
| Interest coverage | 0.16 | 0.13 | 0 | 0 | 0 | |
| Income quality | -16.1 | 1 | -14 | -22 | 1.58 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 38.59 | 31.36 | 35.47 | 40.37 | 41.62 | |
| ROIC | 0 | 0 | 0 | 0 | 0 | |
| Return on tangible assets | 0.01 | 0 | 0.01 | 0.01 | 0.01 | |
| Graham Net | 8.76 | 9.16 | 0.89 | 0.81 | 101.32 | |
| Working capital | 2.46B | 2.48B | 2.5B | 2.52B | 2.53B | |
| Tangible asset value | 2.47B | 2.48B | 2.5B | 2.52B | 2.53B | |
| Net current asset value | 2.46B | 2.48B | 2.5B | 2.52B | 2.53B | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 1.69M | 8.19M | 11M | 6.5M | 3.5M | |
| Average payables | 175.5K | 175.5K | 0 | 2.5M | 2.5M | |
| Average inventory | -1.5M | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0.01 | 0 | 0.01 | 0.01 | 0.01 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
CPAC-SPAC.ST Frequently Asked Questions
What is Creaspac AB (publ) stock symbol ?
Creaspac AB (publ) is a SE stock and trading under the symbol CPAC-SPAC.ST
What is Creaspac AB (publ) stock quote today ?
Creaspac AB (publ) stock price is $103.6 today.
Is Creaspac AB (publ) stock public?
Yes, Creaspac AB (publ) is a publicly traded company.
Company Profile
- Volume Average 88.15K
- Market Capitalization 2.63B
- CEO Mr. John Hedberg
- Headquarters Stockholm,SE
- IPO Date 2021-06-23
-
Website
https://www.creaspac.se 
Creaspac AB (publ) intends to acquire an unlisted company that have significant potential for revaluation and underlying value creation in the Nordic region. The company was founded in 2020 and is based in Stockholm, Sweden.
